SMTI Sanara MedTech Inc
Price (delayed)
$30.07
Market cap
$267.68M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.14
Enterprise value
$284.09M
With a focus on improving patient outcomes through evidence-based healing solutions and services, Sanara MedTech Inc. markets and distributes wound and skin care products and is seeking to offer wound
Highlights
Sanara MedTech's gross profit has increased by 37% YoY and by 12% QoQ
The company's revenue rose by 33% YoY and by 11% QoQ
SMTI's quick ratio has soared by 94% YoY but it is down by 3.5% QoQ
Sanara MedTech's debt has surged by 174% YoY
Sanara MedTech's net income has shrunk by 125% YoY and by 16% QoQ
Key stats
What are the main financial stats of SMTI
Market
Valuations
Earnings
Shares outstanding
8.9M
Market cap
$267.68M
Enterprise value
$284.09M
Price to earnings (P/E)
N/A
Price to book (P/B)
6.67
Price to sales (P/S)
2.94
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.28
Revenue
$86.67M
Gross profit
$78.53M
Operating income
-$8.65M
Net income
-$9.66M
EBIT
-$6.54M
EBITDA
-$1.07M
Free cash flow
-$229,632
Per share
Balance sheet
Liquidity
EPS
-$1.14
EPS diluted
-$1.14
Free cash flow per share
-$0.03
Book value per share
$4.51
Revenue per share
$10.22
TBVPS
$5.13
Total assets
$88.09M
Total liabilities
$49.18M
Debt
$32.29M
Equity
$39.4M
Working capital
$18.02M
Debt to equity
0.82
Current ratio
2.18
Quick ratio
1.92
Net debt/EBITDA
-15.4
Margins
Efficiency
Dividend
EBITDA margin
-1.2%
Gross margin
90.6%
Net margin
-11.2%
Operating margin
-10%
Return on assets
-12%
Return on equity
-23.5%
Return on invested capital
-19.6%
Return on capital employed
-9%
Return on sales
-7.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SMTI stock price
How has the Sanara MedTech stock price performed over time
Intraday
-0.99%
1 week
1.48%
1 month
-13.32%
1 year
-14.6%
YTD
-9.43%
QTD
-2.59%
Financial performance
How have Sanara MedTech's revenue and profit performed over time
Revenue
$86.67M
Gross profit
$78.53M
Operating income
-$8.65M
Net income
-$9.66M
Gross margin
90.6%
Net margin
-11.2%
Sanara MedTech's net income has shrunk by 125% YoY and by 16% QoQ
Sanara MedTech's net margin has shrunk by 70% YoY and by 4.7% QoQ
Sanara MedTech's gross profit has increased by 37% YoY and by 12% QoQ
The company's revenue rose by 33% YoY and by 11% QoQ
Growth
What is Sanara MedTech's growth rate over time
Valuation
What is Sanara MedTech stock price valuation
P/E
N/A
P/B
6.67
P/S
2.94
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.28
SMTI's EPS has dropped by 119% year-on-year and by 15% since the previous quarter
The price to book (P/B) is 40% lower than the 5-year quarterly average of 11.2
SMTI's equity is down by 12% year-on-year
The P/S is 62% lower than the 5-year quarterly average of 7.9 and 18% lower than the last 4 quarters average of 3.6
The company's revenue rose by 33% YoY and by 11% QoQ
Efficiency
How efficient is Sanara MedTech business performance
The company's return on equity has shrunk by 135% YoY and by 19% QoQ
The company's return on assets has shrunk by 88% YoY and by 10% QoQ
SMTI's return on sales is down by 27% year-on-year but it is up by 6% since the previous quarter
Sanara MedTech's return on invested capital has increased by 27% YoY and by 16% QoQ
Dividends
What is SMTI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SMTI.
Financial health
How did Sanara MedTech financials performed over time
The company's total assets is 79% higher than its total liabilities
SMTI's quick ratio has soared by 94% YoY but it is down by 3.5% QoQ
The company's total liabilities has surged by 68% YoY
Sanara MedTech's debt is 18% lower than its equity
Sanara MedTech's debt has surged by 174% YoY
SMTI's equity is down by 12% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.